Most Accessed Articles
Lupus Nephritis: A Treatment Update
, 2018; 13(1): 4-13.Fahad Aziz and Kunal Chaudhary*
DOI: 10.2174/1574884713666180403150359
Monoclonal Antibodies: A Review
, 2018; 13(2): 85-99.Surjit Singh*, Nitish K. Kumar, Pradeep Dwiwedi, Jaykaran Charan, Rimplejeet Kaur, Preeti Sidhu and Vinay K. Chugh
DOI: 10.2174/1574884712666170809124728
Drug-induced QT Interval Prolongation in the Intensive Care Unit
, 2017; 12(4): 210-222.Cecilia Villa Etchegoyen, Guillermo Alberto Keller, Sebastian Mrad, Sixuan Cheng and Guillermo Di Girolamo*
DOI: 10.2174/1574884713666180223123947
Pharmacokinetic and Pharmacodynamic Relationship of Blinatumomab in Patients with Non-Hodgkin Lymphoma
, 2018; 13(1): 55-64.Youssef Hijazi, Matthias Klinger, Andrea Kratzer, Benjamin Wu, Patrick A. Baeuerle, Peter Kufer, Andreas Wolf, Dirk Nagorsen and Min Zhu*
DOI: 10.2174/1574884713666180518102514
Pharmacokinetics and Pharmacokinetic Variability of Heroin and its Metabolites: Review of the Literature
, 2006; 1(1): 109-118.Elisabeth J. Rook, Alwin D.R. Huitema, Wim v. d. Brink, Jan M. v. Ree and Jos H. Beijnen
DOI: 10.2174/157488406775268219
Pharmacogenetics of Glucagon-like Peptide-1 Agonists for the Treatment of Type 2 Diabetes Mellitus
, 2017; 12(4): 202-209.Spyridon N. Karras, Eleni Rapti, Theocharis Koufakis, Angeliki Kyriazou, Dimitrios G. Goulis and Kalliopi Kotsa*
DOI: 10.2174/1574884713666180221121512
An Evidence-Based Review of Off-Label Uses of Polidocanol
, 2017; 12(4): 223-230.Seyyed Reza Sadat Ebrahimi, Elgar Enamzadeh* and Hossein Babaei
DOI: 10.2174/1574884713666180223121828
Pharmacokinetics and Pharmacodynamics of Rivaroxaban – An Oral, Direct Factor Xa Inhibitor
, 2014; 9(1): 75-83.Reinhold Kreutz
DOI: 10.2174/1574884708666131111204658
Endocannabinoid System: A Multi-Facet Therapeutic Target
, 2016; 11(2): 110-117.Rimplejeet Kaur, Sneha R. Ambwani and Surjit Singh
DOI: 10.2174/1574884711666160418105339
Webmaster Contact: info@benthamscience.org